Allergan
In David Einhorn's portfolio · Greenlight Capital
Ticker AGN
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2016 | Sell | 0 | |
| Q1 2016 | Add 7% | 437,200 | 2.0% |
| Q4 2015 | Buy | 410,000 | 2.3% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.